Owens, E., Hotchkiss, K., Threatt, S., Low, J. T., Anand, M., Louw, J., … Khasraw, M. (2026). Abstract 7769: IL-12/anti-PD-1 armored oncolytic HSV-1 reprograms CNS immunity: Integrated longitudinal immune, genomic, and metabolic CSF profiling in the MVR-C5252 PuMP Trial. In Cancer Research (Vol. 86, pp. 7769–7769). American Association for Cancer Research (AACR). https://doi.org/10.1158/1538-7445.am2026-7769

Owens, Elizabeth, Kelly Hotchkiss, Stevie Threatt, Justin T. Low, Monika Anand, Julia Louw, Melody Goldston, et al. “Abstract 7769: IL-12/anti-PD-1 armored oncolytic HSV-1 reprograms CNS immunity: Integrated longitudinal immune, genomic, and metabolic CSF profiling in the MVR-C5252 PuMP Trial.” In Cancer Research, 86:7769–7769. American Association for Cancer Research (AACR), 2026. https://doi.org/10.1158/1538-7445.am2026-7769.

Owens E, Hotchkiss K, Threatt S, Low JT, Anand M, Louw J, et al. Abstract 7769: IL-12/anti-PD-1 armored oncolytic HSV-1 reprograms CNS immunity: Integrated longitudinal immune, genomic, and metabolic CSF profiling in the MVR-C5252 PuMP Trial. In: Cancer Research. American Association for Cancer Research (AACR); 2026. p. 7769–7769.

Owens, Elizabeth, et al. “Abstract 7769: IL-12/anti-PD-1 armored oncolytic HSV-1 reprograms CNS immunity: Integrated longitudinal immune, genomic, and metabolic CSF profiling in the MVR-C5252 PuMP Trial.” Cancer Research, vol. 86, no. 7_Supplement, American Association for Cancer Research (AACR), 2026, pp. 7769–7769. Crossref, doi:10.1158/1538-7445.am2026-7769.

Owens E, Hotchkiss K, Threatt S, Low JT, Anand M, Louw J, Goldston M, Johnson MO, Bradbury C, Herndon JE, Grant GA, Ashley DM, Patel AP, Desjardins A, Brown MC, Khasraw M. Abstract 7769: IL-12/anti-PD-1 armored oncolytic HSV-1 reprograms CNS immunity: Integrated longitudinal immune, genomic, and metabolic CSF profiling in the MVR-C5252 PuMP Trial. Cancer Research. American Association for Cancer Research (AACR); 2026. p. 7769–7769.